Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

Academic Article


  • The NCCN Guidelines for Kidney Cancer focus on the screening, diagnosis, staging, treatment, and management of renal cell carcinoma (RCC). Patients with relapsed or stage IV RCC typically undergo surgery and/or receive systemic therapy. Tumor histology and risk stratification of patients is important in therapy selection. The NCCN Guidelines for Kidney Cancer stratify treatment recommendations by histology recommendations for first-line treatment of ccRCC are also stratified by risk group. To further guidemanagement of advanced RCC, the NCCN Kidney Cancer Panel has categorized all systemic kidney cancer therapy regimens as "Preferred," "Other Recommended Regimens," or "Useful in Certain Circumstances." This categorization provides guidance on treatment selection by considering the efficacy, safety, evidence, and other factors that play a role in treatment selection. These factors include pre-existing comorbidities, nature of the disease, and in some cases consideration of access to agents. This article summarizes surgical and systemic therapy recommendations for patients with relapsed or stage IV RCC.
  • Digital Object Identifier (doi)

    Author List

  • Motzer RJ; Jonasch E; Agarwal N; Alva A; Baine M; Beckermann K; Carlo MI; Choueiri TK; Costello BA; Derweesh IH
  • Start Page

  • 71
  • End Page

  • 90
  • Volume

  • 20
  • Issue

  • 1